Sales for the Mansfield, Mass.-based company's devices segment rose 11.1 percent during the three months ended Dec. 24, 2010, to $1.88 billion. For Covidien's two other segments, pharmaceuticals and medical supplies, the trend was in the opposite direction. Pharma revenues slipped 8.0 percent to $470 million; medical supplies revenues were down 4.7 percent, to $422 million, compared with the same period last year.
ev3 Inc. (NSDQ:EVVV) agreed to settle a group of lawsuits filed by shareholders looking to block its $2.6 billion buyout by Covidien plc (NYSE:COV). The lawsuits, filed in the Hennepin County District Court for Minnesota and Delaware’s Court of Chancery, accused the Plymouth, Minn.-based company’s board of breaching its fiduciary duties in giving a green […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.